Antimicrobial peptides (AMPs) constitute a group of small molecular peptides that exhibit a wide range of antimicrobial activity. These peptides are abundantly present in the innate immune system of various organisms. Given the rise of multidrug-resistant bacteria, microbiological studies have identified AMPs as potential natural antibiotics. In the context of antimicrobial resistance across various human pathogens, AMPs hold considerable promise for clinical applications. However, numerous challenges exist in the detection of AMPs, particularly by immunological and molecular biological methods, especially when studying of newly discovered AMPs in proteomics. This review outlines the current status of AMPs research and the strategies employed in their development, considering resent discoveries and methodologies. Subsequently, we focus on the advanced techniques of mass spectrometry for the quantification of AMPs in diverse samples, and analyzes their application, advantages, and limitations. Additionally, we propose suggestions for the future development of tandem mass spectrometry for the detection of AMPs.
MDR is increasingly common in pathogenic bacteria. The development and application of new antimicrobial drugs is imminent.
The diversity and potency of AMPs make them attractive targets for development as antimicrobial drugs.
Mass spectrometry has become a powerful tool in chemical and biological analysis, and has been applied in the study of AMPs.
Our study focuses on the application of MS/MS detecting AMPs in various samples and analyzes its advantages and limitations.